The Greater Cannabis Company, Inc.

GCAN

US3916571033

Internet Services

Market Closed - OTC Markets Other stock markets 09:41:48 31/05/2024 pm IST			5-day change	1st Jan Change
0.0007 ^USD	-.--%		-.--%	-22.22%

14/05	The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/04	The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

The Greater Cannabis Company, Inc. Announces Resignation of David Tavor as Director

August 19, 2021 at 11:25 pm IST

The Greater Cannabis Company, Inc. announced that effective August 19, 2021, David Tavor resigned as director of the Company.

Latest news about The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	13/23/13	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/23/14	CI
The Greater Cannabis Company, Inc. Auditor Raises 'Going Concern' Doubt	13/23/13	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Greater Cannabis Company, Inc. Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders	07/22/07	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	13/22/13	CI
The Greater Cannabis Company, Inc. Auditor Raises 'Going Concern' Doubt	12/22/12	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	16/21/16	CI
Greater Cannabis Company, Inc. Announces Initiation of Preclinical Study for Neuropsychiatric Cannabinoid Therapy	08/21/08	CI
Greater Cannabis Company, Inc. Signs License and Research Agreement with share Zedek Scientific	08/21/08	CI
The Greater Cannabis Company, Inc. Announces Mark Radom Resigned from His Position of General Counsel of the Company, Effective Immediately	01/21/01	CI
The Greater Cannabis Company, Inc. Announces Resignation of David Tavor as Director	19/21/19	CI
GCANRx Signs Licensing Agreement with share Zedek Scientific for Innovative Neuropsychiatric Cannabinoid Therapy	19/21/19	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	19/21/19	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	17/21/17	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	26/21/26	CI
The Greater Cannabis Company, Inc. Announces Collaboration with Renowned Cannabis Research Lab	16/21/16	CI
The Greater Cannabis Company Announces Launch of Bob Ross Beauty and Cosmetics Products	23/20/23	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	19/20/19	CI

Chart The Greater Cannabis Company, Inc.

Duration

Period

Chart The Greater Cannabis Company, Inc.

More charts

The Greater Cannabis Company, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of cannabinoid therapeutics. The Company conducts medical research, and is pursuing clinical trials, to develop cannabis-based treatments for various medical conditions and their symptoms with an initial focus on neuropsychiatric disorders. The Company conducts clinical studies on and commercialize the cannabinoid-based therapeutic and concentrate on cannabis related investment and development opportunities through direct equity investments, joint ventures, licensing agreements or acquisitions. Its delivery technologies use a bio-adhesive, adjustable dose, and fully dissolvable, non-irritant patch, which provides needle free, intra-oral systemic drug delivery.

Sector

Internet Services

More about the company

Income Statement Evolution

More financial data

Sector Other Internet Services

	1st Jan change	Capi.
THE GREATER CANNABIS COMPANY, INC.	-22.22%	513K
TENCENT HOLDINGS LIMITED	+22.55%	426B
NETFLIX, INC.	+31.87%	277B
UBER TECHNOLOGIES, INC.	+4.92%	135B
AIRBNB, INC.	+6.46%	92.01B
PROSUS N.V.	+23.70%	89.16B
SPOTIFY TECHNOLOGY S.A.	+57.95%	58.86B
DOORDASH, INC.	+11.34%	45.02B
NASPERS LIMITED	+19.19%	34.77B
COSTAR GROUP, INC.	-10.48%	31.96B